Basic treatment of hemodynamic and metabolic disorders in cardiovascular disease
Gilbert, J.C.
Semaine des Hopitaux. Therapeutique 51(9): 463-466
1975
ISSN/ISBN: 0302-9271 PMID: 1198120 Document Number: 93912
Document emailed within 1 workday
Related Documents
Szybínski, Z.; Sznajd, J.; Sieradzki, J.; Magdoń, M.; Mruk, K.; Olszanecki, S. 1976: Structure and basic activities of a consultation unit on metabolic disorders within the programme for prevention of coronary heart disease Przeglad Lekarski 33(6): 579-582Kravchun, P.; Kadykova, O.; Gabisoniia, T. 2012: The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease Georgian Medical News 213: 26-31
Matveev, D.V.; Sergeeva, N.A.; Gel'fand, B.R.; Karalkin, A.V.; Burnevich, S.Z. 1991: Metabolic disorders in peritonitis: hemodynamic or cellular disorders? Sovetskaia Meditsina 8: 3-8
Emerson, T.E.; Raymond, R.M. 1979: Methylprednisolone in the prevention of cerebral hemodynamic and metabolic disorders during endotoxin shock in the dog Surgery Gynecology and Obstetrics 148(3): 361-366
Santangelo, G.; Barberi, I.; Sorbello, A.; Lombardo, S. 1970: Basic concepts of metabolic platelet disorders in patients with Ancylostoma duodenalis Haematologica 55(12): 735-748
Sobieszczańska, Młgorzata.; Kałka, D.; Pilecki, W.; Adamus, J. 2009: Physical activity in basic and primary prevention of cardiovascular disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 26(156): 659-664
Bognounou, R.; Diendéré, A.; Diallo, I.; Tieno, H.; Guira, O.; Ouedraogo, D.D.; Drabo, Y.J. 2011: Metabolic disorders and cardiovascular risk factors observed in patients infected by the HIV with antiretroviral therapy in Burkina Faso Medecine Tropicale: Revue du Corps de Sante Colonial 71(6): 626-627
Vitarius, J.A. 2005: The metabolic syndrome and cardiovascular disease Mount Sinai Journal of Medicine new York 72(4): 257-262
Vaishnava, H.; Hagroo, A.A. 1973: Clinical and metabolic profile in diabetic cardiovascular disease Journal of the Indian Medical Association 61(4): 159-166
Bano, K.A.; Batool, A. 2007: Metabolic syndrome, cardiovascular disease and type-2 diabetes JPMA. Journal of the Pakistan Medical Association 57(10): 511-515
Kozłowska, A.; Kowalska, I. 2006: The role of adiponectin in pathogenesis of metabolic syndrome and cardiovascular disease Endokrynologia Polska 57(6): 626-632
Guo, L.; Hu, X-shu.; Guo, Z-rong.; Kang, G-dong.; Wu, M.; Zhou, H. 2009: Association and interaction between the components of metabolic syndrome and cardiovascular disease Zhonghua Xin Xue Guan Bing Za Zhi 37(7): 644-647
Nowak, M.; Grzywa, M. 2011: Metabolic obesity in normal weight individuals and cardiovascular disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 31(182): 118-121
Shkrebets, G.V. 2011: Medical treatment for correction of hemodynamic, rheological and metabolic changes in young patients with glaucoma associated with myopia Vestnik Oftalmologii 127(5): 38-41
Ford, E.S. 2005: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28(7): 1769-1778
Medvedeva, I.V.; Dorodneva, E.F.; Pugacheva, T.A.; Belokorylova, L.V.; Shorokhova, T.D.; Ushakova, M.A. 2002: Analysis of lipid plasma spectrum and basic parameters of red cell membranes in patients with metabolic syndrome and ischemic heart disease Klinicheskaia Meditsina 80(5): 27-30
Moon, P.F.; Gabor, L.; Gleed, R.D.; Erb, H.N. 1997: Acid-base, metabolic, and hemodynamic effects of sodium bicarbonate or tromethamine administration in anesthetized dogs with experimentally induced metabolic acidosis American Journal of Veterinary Research 58(7): 771-776
Suárez-Moro, R.; Castaño-García, B. 2010: Cardiovascular disorders in Parkinson's disease Revista de Neurologia 50(Suppl 2): S59-S63
Vecherskiĭ, G.A. 1978: Hormonal and metabolic disorders in ischemic heart disease Kardiologiia 18(12): 36-40
Zhang, C.; Liu, J.; Pan, H.; Yang, X.; Bian, K. 2011: Mitochondrial dysfunction induced by excessive ROS/RNS-metabolic cardiovascular disease and traditional Chinese medicines intervention Zhongguo Zhong Yao Za Zhi 36(17): 2423-2428